
ALT Virtual Thalassemia Grand Rounds. A virtual forum for healthcare providers to learn the latest in the diagnosis, treatment, and management of thalassemia A photo of the presenter, Dr. Farzana Sayani, MD, Msc, FRCPC A photo of the moderator, Scott A. Peslak, MD, PhD Disease Management Considerations for People with Thalassemia Older than 50 February 21, 2025, 2-3 PM ET

ALT CDC's Sickle Cell Data Collection program builds bridges between community-based organizations and scientists to improve the lives of people with sickle cell disease. What did we learn from these partnerships? Illustration of a hexagon with SCDC Sickle Cell Data Collection and 6 lessons learned in each corner. -(icon of handshake) Prioritize trust-building -(icon of a checklist) Establish shared goals and define expectations -(icon of puzzle pieces) Leverage strengths for mutual benefit -(icon of people talking) Incorporate community voices from the beginning -(icon of chat bubbles) Foster open communication -(icon of illustration of network of people) Seek out diverse partnerships and perspective Consider how these lessons can help your program build stronger partnerships. Young AJ, Maresh A, Pope S, et al. Improving the Lives of People with Sickle Cell Disease: Community Organizations and Epidemiologists Working Together. Prog Community Health Partnersh. 2024;18(3):371-380.

ALT The graphic shows icons of a person going up stairs, a person looking at a laptop, and a child pulling on an adult’s arm. Text reads, “1 in 5 adults experiencing Long COVID report major limitations in performing daily activities. Policymakers can use these estimates to support plans, policies, and programs that advocate for adults experiencing Long COVID.

ALT Woman holds and kisses baby. Text reads: "Perinatal Hepatitis C: SCREEN patients for hepatitis C during each pregnancy; TEST all perinatally exposed infants for hepatitis C infection at age 2 - 6 months; MANAGE infants with an HCV RNA+ test alongside a provider with pediatric hepatitis C expertise."

ALT A child in a hospital bed. Text reads, "A sickle cell disease clinic in Atlanta, GA, found the rate of severe anemia due to parvovirus B19 infection in children with sickle cell disease more than tripled in 2024 compared to the previous 14 years combined."

ALT A clinician looking at a tablet. Text reads, "Providers, consider testing for parvovirus B19 in people who have compatible symptoms and are at higher risk of severe disease, including people who are: pregnant; immunocompromised; have chronic hemolytic blood disorders (such as sickle cell disease)."























